ES2164564A1 - Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii. - Google Patents
Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii.Info
- Publication number
- ES2164564A1 ES2164564A1 ES009902287A ES9902287A ES2164564A1 ES 2164564 A1 ES2164564 A1 ES 2164564A1 ES 009902287 A ES009902287 A ES 009902287A ES 9902287 A ES9902287 A ES 9902287A ES 2164564 A1 ES2164564 A1 ES 2164564A1
- Authority
- ES
- Spain
- Prior art keywords
- amides
- inhibitors
- cancer
- esters
- combined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Bencenos trisustituidos unidos a amidas, ésteres y ácidos carboxílicos como nuevos inhibidores de la ciclooxigenasa II. La presente invención se refiere a compuesto de fórmula general I, **FORMULA** inhibidores selectivos de la ciclooxigenasa-II, en los que el grupo D es un grupo - C(R{sup,2}) (R{sup,3}) -C(R{sup,4}) (R{sup,5})-, - C(R{sup,2})=C(R{sup,4}- ó -C C-; A es un birradical -CO-, -O-, -S-, ó -NH-; X es un átomo de oxígeno o un grupo -N(R{sup,6})- y E es halógeno, (C{sub,1}-C{sub,6})-alquilo, (C{sub,2}- C{sub,6})-alquenilo, C{sub,2}-C{sub,6 })-alquinilo, etc., a sus sales y solvatos farmacéuticamente aceptables, y a las composiciones farmacéuticas que las contiene. Los compuestos de la presente invención son útiles en el tratamiento de la inflamación, dolor y fiebre, así como de aquellas otras afecciones que recientemente se han asociado con las cilooxigenasas, especialmente con la ciclooxigenasa-II, como ejemplo el cáncer colorectal y Alzheimer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9902287A ES2164564B1 (es) | 1999-10-18 | 1999-10-18 | Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9902287A ES2164564B1 (es) | 1999-10-18 | 1999-10-18 | Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2164564A1 true ES2164564A1 (es) | 2002-02-16 |
ES2164564B1 ES2164564B1 (es) | 2003-02-16 |
Family
ID=8310284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9902287A Expired - Fee Related ES2164564B1 (es) | 1999-10-18 | 1999-10-18 | Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2164564B1 (es) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0436199A1 (en) * | 1989-12-28 | 1991-07-10 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
EP0527458A1 (de) * | 1991-08-13 | 1993-02-17 | Roche Diagnostics GmbH | Neue 3,5-Di-tert.butyl-4-hydroxyphenyl-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
US5604253A (en) * | 1995-05-22 | 1997-02-18 | Merck Frosst Canada, Inc. | N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors |
JPH10182583A (ja) * | 1996-12-25 | 1998-07-07 | Mitsui Chem Inc | 新規ヒドロキサム酸誘導体 |
-
1999
- 1999-10-18 ES ES9902287A patent/ES2164564B1/es not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0436199A1 (en) * | 1989-12-28 | 1991-07-10 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
EP0527458A1 (de) * | 1991-08-13 | 1993-02-17 | Roche Diagnostics GmbH | Neue 3,5-Di-tert.butyl-4-hydroxyphenyl-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
US5604253A (en) * | 1995-05-22 | 1997-02-18 | Merck Frosst Canada, Inc. | N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors |
JPH10182583A (ja) * | 1996-12-25 | 1998-07-07 | Mitsui Chem Inc | 新規ヒドロキサム酸誘導体 |
Non-Patent Citations (1)
Title |
---|
STANKEVICIUS, A. y col. "Synthesis and spectral properties of phthalimidines and phthalides". Khim. Geterotsikl. Soedin., 1992, No 4, paginas 472-6 (resumen) HCAPLUS [en linea]. Londres (Reino Unido) [recuperado el 12.11.2001]. Recuperado de STN International, Columbus, Ohio (EE.UU) No acceso 1992:633774. RN 144402-64-2 y RN 119935-62-5 * |
Also Published As
Publication number | Publication date |
---|---|
ES2164564B1 (es) | 2003-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03005342A (es) | Derivados de carboxamida y su uso en tratamiento de enfermedades tromboembolicas y tumores. | |
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
ZA983451B (en) | Substituted imidazoles useful in the treatment of inflammatory diseases. | |
MY124214A (en) | Compositions for promoting crowth | |
MY138059A (en) | Use of ikb-kinase inhibitors in pain therapy | |
NO20014046D0 (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
IL144214A0 (en) | Benzoheterocycles and their use as mek inhibitors | |
DK1390049T3 (da) | Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor | |
IL158559A0 (en) | Acne treatment | |
AU3021001A (en) | Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer | |
ZA200108413B (en) | Use of glycosyceramide synthesis inhibitors in therapy. | |
EP1009404A4 (en) | PROCESS FOR TREATING INFLAMMATION OR INFLAMMATORY DISEASES USING POLY-ADP RIBOSE POLYMERASE INHIBITORS | |
FR2754820B1 (fr) | Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant | |
HUS1000019I1 (hu) | Karbonsav-tartalmú szerek és növénytermesztésben való alkalmazásuk | |
WO1999020260A3 (en) | The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function | |
IS5220A (is) | Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum | |
EP1198255A4 (en) | IDENTIFICATION OF SUBSTANCES THAT MODIFY TRANSCRIPTIONAL ANSWERS TO HYPOXIA | |
AU2001270484A1 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
IS5713A (is) | Blöndur prótín-farnesýlfærsluensíms- og HMG COA afoxunarensímstálma og notkun þeirra til meðhöndlunar á krabbameini | |
ES2164564A1 (es) | Bencenos trisustituidos unidos a amidas, esteres y acidos carboxilicos como nuevos inhibidores de la ciclooxigenasa ii. | |
MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
HK1047107A1 (en) | Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors. | |
FR2704394B1 (fr) | Complément nutritionnel absorbable pour le traitement des cheveux et des ongles. | |
AU2003270350A1 (en) | Isoxazoles and their use in the treatment of ischemic diseases | |
AU5682900A (en) | Combination of mtp inhibitors and active agents that influence the metabolism and use thereof in medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20020216 Kind code of ref document: A1 Effective date: 20020216 |
|
FG2A | Definitive protection |
Ref document number: 2164564B1 Country of ref document: ES |
|
FD1A | Patent lapsed |
Effective date: 20100623 |